Understanding how SARS-CoV-2 vaccines affect immunity
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
This study is looking at how well our immune systems respond to COVID-19 vaccines compared to getting the virus itself, to see which offers better and longer-lasting protection, and it's for anyone interested in understanding more about COVID-19 immunity.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10855012 on NIH RePORTER |
What this research studies
This research investigates the immune responses generated by SARS-CoV-2 vaccination and natural infection. It aims to identify specific antibody profiles that correlate with protection against COVID-19, using data from both vaccinated individuals and those who have recovered from the virus. The study will also explore how long these immune responses last and whether vaccination provides more durable immunity compared to natural infection. By analyzing these factors, the research seeks to enhance our understanding of COVID-19 immunity and improve vaccine strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have received a SARS-CoV-2 vaccine or those who have recovered from COVID-19.
Not a fit: Patients who have not been vaccinated against SARS-CoV-2 and have not had a prior infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine designs and strategies that enhance long-term immunity against COVID-19.
How similar studies have performed: Other research has shown promising results in understanding immune responses to vaccines, making this approach both relevant and potentially impactful.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Barouch, Dan H. — Beth Israel Deaconess Medical Center
- Study coordinator: Barouch, Dan H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.